DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / Healthcap Advisor Ab
Healthcap Advisor Ab
This firm files as 5 advisers on healthcap.ch: Healthcap Ix Advisor Ab, Healthcap VII Advisor Ab, Healthcap Viii Advisor Ab, OFP V Advisor Ab. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
venture manager, reported GAV $9.4M across 1 vehicles
Importance
28
moderate
Active deployment
30
moderate
Emerging
0
low
Completeness
75
high
Freshness
100
high
Research priority
11
low
Identity and regulatory footprint
- Headquarters
- Stockholm, Swedenadviserinfo.sec.gov
- Office address
- ENGELBREKTSPLAN 1, Stockholm, 114 34adviserinfo.sec.gov
- Business phone
- 46(8) 442 5850adviserinfo.sec.gov
- Website
- HTTP://HEALTHCAP.CH
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- private fund adviseradviserinfo.sec.gov
- Latest Form ADV
- May 13, 2024
- Private funds reported
- 1 (1 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $9.4Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Owners on Schedule A
- Douvelle Ab (Owner), C; Amberjack Ab (Owner), B; Healthback Ab (Shareholder), B; Cantando Ab (Owner), B; Lindhold Ab (Owner), B; Ibid Ab (Owner), B
- business email
- tyra.kuller@healthcap.euhealthcap.eupublished by the subject
- business email
- carl.kilander@healthcap.euhealthcap.eupublished by the subject
- business phone
- 46(8) 442 5850adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
41 observed deals
Stated (the firm’s website)
- Sectors
- healthcare, biotech, climate, media
- Stages
- not stated or not yet read
- Geography
- global, globally
- Check size
- not stated; DFX does not estimate checks from round sizes
- Self-described
- venture capital
Observed (from deals on record)
Stage at participation
series a 50%series c 50%
Stage at first entry
series a 50%series c 50%
Sectors
unknown 92%Biotechnology 8%
lead rate 50%follow-on rate 0%new logos, 12 months 40
Funds and vehicles
1 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Healthcap VI LP | Fund | 2011 form d first sale | Harvest | $9.4M May 13, 2024 | 9 | $147M of $200M | Jan 25, 2013 |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
31 current, 1 departed
Josefine Persson
AssociateAssociate | MSc
Nikolai Paus
AssociateAssociate I BSc
Nima Barati
AssociateMedical Associate I MD
Shamim Dadvar
AssociateAssociate | MD PhD
Thomas Ramdahl
General partnerDirector, GP | MSc PhD
Vanessa Malier
General partnerDirector, GP | MSc
Sofie Wennerqvist
OtherInvestment Monitor
Alex Valcu
PartnerPartner | MSc
Anki Forsberg
PartnerPartner and Chairman | LLM MBA
Carl Kilander
PartnerPartner | MD PhD
Daniel Karsberg
PartnerPartner | MSc
Fabrice Bernhard
PartnerGeneral Manager | MSc
Johan Christenson
PartnerPartner | MD PhD
Johan Christenson
PartnerSole Shareholder · since Mar 1, 2007
Kristina Ekberg
PartnerPartner | LLM
Kristina Ekberg
PartnerOwner · since Jun 1, 2021
Max Odlander
PartnerPartner | MSc
PER Johan Ture Samuelsson
PartnerSole Shareholder · since Aug 1, 2009
Per Samuelsson
PartnerPartner | MSc
Staffan Lindstrand
PartnerSole Shareholder · since May 1, 1999
Staffan Lindstrand
PartnerPartner | MSc
Marile Schiess
Platform and operationsHead of Compliance I MSc
Nattiya Simmano
Platform and operationsOffice Manager
ANN Christine Forsberg
PrincipalDirector · since Jan 1, 2012
Bjorn Odlander
PrincipalDirector · since Jan 1, 2012
Marten Steen
PrincipalDirector · since May 1, 2022
Oern R. Stuge
PrincipalDirector I MD MBA
PER Olof Eriksson
PrincipalDirector · since Jan 1, 2012
Carl-Johan Dalsgaard
Venture partnerVenture Partner | MD PhD
Eugen Steiner
Venture partnerVenture Partner | MD PhD
Georg Vo Beiske
Venture partnerVenture Partner | MSc
1 departed (kept with end dates)
- Jacob Gunterberg · Sole Shareholder · Dec 1, 2009 to Apr 10, 2023 Inference
Investments on record
41 edges, 38 companies, 1 partner-attributed
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
18 relationships from shared deals, counted for the whole firm
Mitsui & Co. Global Investment, Inc. 1 shared · one timeBiogeneration III Services B.V. 1 shared · one timeOmega Fund Management, LLC 1 shared · one timeAsset Management Ventures, LLC 1 shared · one timeSofinnova Investments, Inc. 1 shared · one timeHBM Healthcare Investments 1 shared · one timeGrdnt LLC 1 shared · one timeAvoro Capital Advisors LLC 1 shared · one timeCrane Venture Partners LLP 1 shared · one timeLifeline Ventures 1 shared · one time · we led 1Sandwater 1 shared · one time · they led 1 · we led 1Deep Track Capital 1 shared · one timeSofinnova Partners 1 shared · one time · they led 1Maj Invest Equity 1 shared · one timeNovo Holdings 1 shared · one timeInvus 1 shared · one timeAccess Biotechnology 1 shared · one timeAvoro Ventures 1 shared · one time
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
19 dated events
- Sep 16, 2026Howtogetridofwartshome no longer listed on Healthcap Advisor Ab's portfolio pageRemoved from portfolio pagePortfolioInferenceHowtogetridofwartshomeVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026myelodysplastic syndrome no longer listed on Healthcap Advisor Ab's portfolio pageRemoved from portfolio pagePortfolioInferencemyelodysplastic syndromeVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026anthracycline extravasation no longer listed on Healthcap Advisor Ab's portfolio pageRemoved from portfolio pagePortfolioInferenceanthracycline extravasationVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026heparin-induced thrombocytopenia no longer listed on Healthcap Advisor Ab's portfolio pageRemoved from portfolio pagePortfolioInferenceheparin-induced thrombocytopeniaVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026pulmonary embolism no longer listed on Healthcap Advisor Ab's portfolio pageRemoved from portfolio pagePortfolioInferencepulmonary embolismVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026deep vein thrombosis no longer listed on Healthcap Advisor Ab's portfolio pageRemoved from portfolio pagePortfolioInferencedeep vein thrombosisVenture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026low molecular weight heparin no longer listed on Healthcap Advisor Ab's portfolio pageRemoved from portfolio pagePortfolioInferencelow molecular weight heparinVenture organization websites (about, team, portfolio, thesis, news pages)
- Apr 10, 2023Jacob Gunterberg (Sole Shareholder) no longer on Schedule A of Healthcap Advisor Ab
- May 1, 2022Marten Steen joined Schedule A of Healthcap Advisor Ab as Director
- May 1, 2022Kristina Ekberg joined Schedule A of Healthcap Advisor Ab as Director
- Mar 31, 2016Healthcap VI LP first reported on Form ADV by Healthcap Advisor Ab (Venture Capital Fund)Fund first reported on Form ADVFundsFactHealthcap VI LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2012Healthcap Advisor Ab first filed Form ADV (ERA)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jan 1, 2012ANN Christine Forsberg joined Schedule A of Healthcap Advisor Ab as Director
- Jan 1, 2012Bjorn Odlander joined Schedule A of Healthcap Advisor Ab as Director
- Dec 1, 2009Jacob Gunterberg joined Schedule A of Healthcap Advisor Ab as Sole Shareholder
- Aug 1, 2009PER Johan Ture Samuelsson joined Schedule A of Healthcap Advisor Ab as Sole Shareholder
- Mar 1, 2007Johan Christenson joined Schedule A of Healthcap Advisor Ab as Sole Shareholder
- May 1, 1999PER Olof Eriksson joined Schedule A of Healthcap Advisor Ab as Sole Shareholder
- May 1, 1999Staffan Lindstrand joined Schedule A of Healthcap Advisor Ab as Sole Shareholder
Classification history
- Sep 12, 2026Micro VC (probable, 80%, cls-1)venture manager, reported GAV $9.4M across 1 vehicles
Evidence
43 observations from 2 sources